Ashish Y. Pawar , Kiran B. Erande , Deepak D. Sonawane , Vikas R. Asawale , Yogesh S. Harak , Deelip V. Derle
{"title":"Compressed glyceryl monostearate based biodegradable implant of Gentamicin using melt granulation technique: In vitro evaluation & biocompatibility in animals","authors":"Ashish Y. Pawar , Kiran B. Erande , Deepak D. Sonawane , Vikas R. Asawale , Yogesh S. Harak , Deelip V. Derle","doi":"10.1016/j.dit.2013.03.006","DOIUrl":"10.1016/j.dit.2013.03.006","url":null,"abstract":"<div><h3>Objective</h3><p>Osteomyelitis is a multibacterial bone infection which is still remains challenging and difficult to treat, despite of advances in antibiotics and new operative techniques. Present study aims at formulating Gentamicin implants in treatment of Osteomyelitis & other bone infections using glyceryl monostearate (GMS) matrices as a carrier.</p></div><div><h3>Methods</h3><p>Gentamicin implants were prepared by using combination of glyceryl monostearate and poly ethylene glycol as hydrophobic biodegradable sustained release matrices along with different percentage of Sorbitol and Tween80 as erosion enhancers. Several formulations were prepared (K1–K7) by melt granulation followed by compression to form disc shaped implants. The prepared formulations were evaluated for different <em>in vitro</em> parameters & optimized formulation was subjected to <em>in vivo</em> study.</p></div><div><h3>Results & discussion</h3><p>Formulation K4 shows excellent cumulative drug release profile and it does not completely lose its physical shape even after 28 days thus this formulation conclude to be optimum formulation among the all GMS based implant formulations. Also optimized GMS based implant does not show any severe signs of inflammation and other foreign body reactions in laboratory animals, thus it was concluded that GMS based implant have acceptable biological compatibility even after 28 days.</p></div><div><h3>Conclusion</h3><p>Therefore from this study it is proved that, the glyceryl monostearate based implants have potential to retard the drug release for more than five weeks in the treatment of osteomyelitis & bone infections.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 39-49"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74159257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"RETRACTED: Nanosuspension of vasicine from Adhatoda vasica: Isolation and characterization","authors":"Jitender Kumar Malik , Akshat Sharma , Sanjiv Singh , Sourabh Jain","doi":"10.1016/j.dit.2013.03.005","DOIUrl":"10.1016/j.dit.2013.03.005","url":null,"abstract":"<div><p>This article has been retracted: please see Elsevier Policy on Article Withdrawal (<span>http://www.elsevier.com/locate/withdrawalpolicy</span><svg><path></path></svg>).</p><p>This article has been retracted at the request of the Authors. The article was published with the omission of a legitimate author, Shailendra Singh, CSIR-Advanced Materials and Processes Research Institute (AMPRI).</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 32-38"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80535131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fabrication of highly stable sonication assisted curcumin nanocrystals by nanoprecipitation method","authors":"C. Moorthi, K. Kathiresan","doi":"10.1016/j.dit.2013.02.003","DOIUrl":"10.1016/j.dit.2013.02.003","url":null,"abstract":"<div><h3>Objectives</h3><p>The present study was aimed to fabricate highly stable sonication assisted curcumin nanocrystals by nanoprecipitation method to overcome the poor aqueous solubility of curcumin.</p></div><div><h3>Methods</h3><p>Sodium lauryl sulfate coated curcumin nanocrystals and poloxamer 188 coated curcumin nanocrystals were prepared using nanoprecipitation method and characterized for particle size and related parameters.</p></div><div><h3>Results</h3><p>Poloxamer 188 coating has produced a significant size reduction in the distribution width (approximately 250 times in D 90) and in the average particle size (approximately 260 times in volume weight mean) with respect to pure curcumin. Similarly, sodium lauryl sulfate coating has produced a significant size reduction in the distribution width (approximately 1000 times in D 90) and in the average particle size (approximately 750 times in volume weight mean) with respect to pure curcumin. Sodium lauryl sulfate coated curcumin nanocrystals has shown a narrow distribution even after one week than the poloxamer coated curcumin nanocrystals.</p></div><div><h3>Conclusions</h3><p>The study concludes that the anionic nature of sodium lauryl sulfate has provided higher zeta potential and offered high electrostatic force which overcomes the van der Waals force of attraction and gravitational force leading to prevention of nanocrystal aggregation resulting in narrow sized high stable curcumin nanocrystals.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 66-69"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.02.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82571366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preparation and evaluation of Bacopa–phospholipid complex for antiamnesic activity in rodents","authors":"Prasanna Habbu , Smita Madagundi , Ramesh Kulkarni , Sagar Jadav , Rashmi Vanakudri , Venkatrao Kulkarni","doi":"10.1016/j.dit.2013.02.004","DOIUrl":"10.1016/j.dit.2013.02.004","url":null,"abstract":"<div><h3>Objectives</h3><p><em>Bacopa</em>–phospholipid complex (BPC), a novel phytoformulation was prepared, characterized and evaluated for its possible enhancement of antiamnesic activity as compared to bacopa extract (BE) in natural aging induced amnesic mice.</p></div><div><h3>Methods</h3><p>BPC was characterized by scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and FTIR. Antiamnesic activity of BPC (40 mg/kg body weight) and BE (40 mg/kg body weight) was evaluated using elevated plus-maze (EPM), Morris water maze (MWM) and Passive shock avoidance (PSA) tests.</p></div><div><h3>Results</h3><p>SEM data showed that BPC has irregular size vesicles consisting of phoaphatidylcholine (PC) and BE was found to be intercalated in the lipid layer. BPC showed two endothermal peaks (80.90 °C and 171 °C) in DSC studies. Aged mice showed poor retention of memory in EPM, MWM and PSA models. Administration of BPC (40 mg/kg; p.o.) and BE (40 mg/kg; p.o.) significantly reversed cognitive deficits in aged mice. However, enhanced antiamnesic activity was observed with BPC as compared to BE in all the memory models tested. This is also supported by enhanced acetyl cholinesterase inhibitory activity of BPC. A higher serum concentration of bacopaside-I (12.21 μg/ml) and bacopaside-II (12.28 μg/ml) was observed for BPC in bioavailability studies as compared to BE. BPC maintained effective concentration of bacopasides for a longer period in rat serum.</p></div><div><h3>Conclusion</h3><p><em>Bacopa</em>–phospholipid complex has shown improved antiamnesic activity as compared to <em>bacopa</em> extract at the dose studied. This might be due to better absorption of bacopasides from the complex.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 13-21"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.02.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89525264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies","authors":"Aathi Muthusankar, Piramanayagam Shanmughavel","doi":"10.1016/j.dit.2013.02.002","DOIUrl":"10.1016/j.dit.2013.02.002","url":null,"abstract":"<div><h3>Objectives</h3><p>The human N-myc downstream-regulated gene 2 (hNDRG2) protein is mainly responsible for Alzheimer's disease (AD). It has 371 amino acid residues in their sequence. The 3dimensional (3D) structure of the complete sequence of this protein is still unknown. The present research computationally emphases to predict the 3D structure for the complete sequence of hNDRG2 protein and efficiency of this protein against AD was evaluated with synthetic and natural compounds using docking studies. Molecular dynamics (MD) study was performed to find the stability of the best interacted molecule.</p></div><div><h3>Methods</h3><p>The hNDRG2 protein was modeled using Modeller9v10. The lead compounds were retrieved from PubChem database. Docking studies were performed using AutoDock4.2. MD study was done by Macro model.</p></div><div><h3>Results</h3><p>The modeled hNDRG2 protein was validated using Ramachandran plot and it showed the value of 90.8% in the most favored regions. From the results of docking studies, the interaction of modeled protein with synthetic tacrine showed the binding energy value of −4.44 kcal/mol and the interactions with 15 phytocompounds of <em>Rosmarinus officinalis</em>, a natural compound (+)-borneol showed the best binding energy value of −4.64 kcal/mol. The result of MD study determined that, the complex of modeled protein with (+)-borneol was stable at 2.2 ns.</p></div><div><h3>Conclusions</h3><p>In the above study, when the interaction of phytocompounds compared with synthetic tacrine, the natural compound (+)-borneol have showed good interaction with modeled protein and it is suggested to treat AD for avoiding the side effects of synthetic drugs.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 22-27"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.02.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87280997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Review on Prosopis cineraria: A potential herb of Thar desert","authors":"Akash Garg , Sanjeev K. Mittal","doi":"10.1016/j.dit.2013.03.002","DOIUrl":"10.1016/j.dit.2013.03.002","url":null,"abstract":"<div><p><em>Prosopis cineraria</em> (L.) Druce is an important herbal plant as mentioned in ancient literature. It is used traditionally for treatment of various ailments like leprosy, dysentery, asthma, leucoderma, dyspepsia and earache etc. Various phytoconstituents like tannins (gallic acid), steroids (Stigmasterol, campesterol, sitosterol etc), Flavone derivatives (Prosogerin A, B, C, D, and E), alkaloids (Spicigerine, Prosophylline) etc has been isolated from the plant. Pharmacological activities like analgesic, antipyretic, antihyperglycemic, antioxidant, antihypercholesterolemic, antitumor, nootropic have been reported from different plant extracts. The present paper deals with review of phytoconstituents and pharmacological action of plant <em>P. cineraria</em>.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 1","pages":"Pages 60-65"},"PeriodicalIF":0.0,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.03.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88113184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}